Brief: Lundbeck, Otsuka launches schizophrenia drug in Europe
17/03/2014 07:55
COPENHAGEN, March 17 (Reuters) - Danish pharmaceutical company H Lundbeck A/S LUN.CO said on Monday: * Schizophrenia drug Abilify Maintena is now available in a number of European countries * Denmark is the first European country where Abilify Maintena is fully reimbursed * More than ten markets are expected to launch Abilify Maintena by the end of 2014 ((Copenhagen newsroom, tel: +45 33969655, e-mail: copenhagen.newsroom@thomsonreuters.com)) ((For more news, double-click on LUN.CO ))